CN104991067A - Preparation method and applications of anti-ASCA antibody test paper - Google Patents
Preparation method and applications of anti-ASCA antibody test paper Download PDFInfo
- Publication number
- CN104991067A CN104991067A CN201410412017.8A CN201410412017A CN104991067A CN 104991067 A CN104991067 A CN 104991067A CN 201410412017 A CN201410412017 A CN 201410412017A CN 104991067 A CN104991067 A CN 104991067A
- Authority
- CN
- China
- Prior art keywords
- pad
- asca
- antibody
- protein
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention discloses an anti-ASCA antibody test paper, a preparation method and applications thereof. The test paper strip comprises a sample pad (1), a bonding pad (2), an analysis membrane (3), a water absorption pad (6), a bottom plate (7), a detection band T line (4) and a quality control band C line (5), wherein the analysis membrane (3) is adhered on the upper portion of the bottom plate (7), the bonding pad (2) and the water absorption pad (6) are respectively adhered on both ends of the upper portion of the analysis membrane (3), the sample pad (1) is adhered on one end of the upper portion of the bonding pad (2), and the detection band T line (4) and the quality control band C line (5) are arranged on the analysis membrane (3). According to the present invention, the indirect immunodetection method is used and the ASCA antigen protein is used to achieve the high-sensitivity, high-specificity and rapid detection on the anti-ASCA antibody in the sample so as to provide the basis for the clinical assisted diagnosis of Crohn's diseases and other autoimmune diseases.
Description
Technical field
The present invention relates to field of immunoassay detection.Specifically, the present invention relates to a kind of preparation method and the application that detect the immunity chromatography detection test paper of anti-ASCA antibody.
Background technology
Inflammatory bowel disease (inflammatory bowel disease, IBD) be a kind of cause of disease chronic nonspecific inflammatory bowel disease still not fully aware of, comprise ulcerative colitis (ulcerative colitis, and Crohn disease (Crohn ' sdisease, CD) UC).Crohn disease was described in 1932 the earliest by Crohn, Ginzterg and Oppenheime, therefore obtained this name.This disease was once called as again " regional enteritis ", " segmental enteritis ", " chronic intestines wall holostrome scorching " etc.1973, this disease was named as Crohn is sick by the council of medical science international organization of the World Health Organization (WHO).Its feature is that the cause of disease is not bright, is more common in young people, shows as granulomatous inflammation pathology, merges fiberization and ulcer.Can invade and complete GI any position, comprise oral cavity, anus, pathology is segmental or jumping characteristic distribution, and can to invade and beyond enteron aisle, particularly skin.Clinical manifestation is diversified because diseased region, scope and degree are different, and the course of disease is slow, easily recurs.
IBD is the common disease in North America and Europe, and over nearly 30 years, the Japanese IBD incidence of disease is also in progressively increasing trend, though China there is no the epidemiologic data of general population, the medical number of this disease is in progressively increasing trend then clearly during the nearly last ten years.The complicated clinical manifestation of IBD is various, not only has symptom of digestive tract, and intestines also can be had outward to show.Because symptom is non-specific enteritis performances such as suffering from abdominal pain, suffer from diarrhoea, have blood in stool, CD and UC, and other enteron aisle chronic diseases such as IBD and tuberculous enteritis are difficult to antidiastole.
The biomarker of current discriminating UC and CD mainly concentrates on autoimmune antibody and antimicrobial antibody.Wherein anti-S. cervisiae mannans IgA (anti-Saccharomyces cerevisiae immunoglobulin A, and anti-S. cervisiae mannans IgG (anti-Saccharomyces cerevisiae immunoglobulin G ASCA-IgA), ASCA-IgG) be two kinds by the CD index of clinical extensive accreditation, the CD patient ASCA-IgG of nearly 35 ~ 50% is positive, separately have an appointment 25 ~ 30% CD patient ASCA-IgA positive.
Existing anti-ASCA-IgA and ASCA-IgG antibody detection method is enzyme linked immunosorbent assay (ELISA), because the ASCA relevant to CD has IgG and IgA two type, ELISA method needs to detect respectively, and operating process needs professional to detect, operation steps is complicated, and detection time is longer, generally needs 6-10 hour.
The present invention's ASCA antigen of extraction purification home-brewed yeast cell wall, is coated on detection zone or pad, and develop the color anti-ASCA-IgG and anti-ASCA-IgA band respectively or simultaneously.Compared with prior art ELISA, the immuno-chromatographic test paper strip of the present invention's collaurum/colored latex mark preparation, realizes detecting IgG and IgA antibody simultaneously.
Immunochromatographic method (immunochromatography) is a kind of quick diagnosis technology of rising in recent years, its principle is a certain zone special antibody being first fixed on nitrocellulose filter or cellulose acetate membrane, after sample (urine or serum) is immersed in cellulose one end of this drying, due to capillarity, sample will move forward along this film, when moving to the region being fixed with antibody, in sample corresponding antigen namely with this antibody generation specific binding, form macroscopic detection zone.The trace labelling particle that existing immuno-chromatographic test paper strip product is conventional has nm of gold, nanometer selenium, colored latex etc., and be wherein most widely used with nm of gold, nm of gold is also referred to as collaurum.
Immune colloidal gold technique (Immune colloidal goldtechnique, GICT) is called using collaurum as the immunochromatography technique spy of missing label.Collaurum be by gold chloride (HAuCl4) at reductive agent as under the effect such as white phosphorus, ascorbic acid, sodium citrate, tannic acid, polymerization becomes the gold grain of specific size, and gains the name because electrostatic interaction becomes a kind of stable colloidal state.Collaurum is electronegative under mild alkaline conditions, can be formed firmly be combined, because this combination is electrostatical binding, so do not affect the biological nature of protein with the positive charge group of protein molecule.Collaurum except with protein bound except, can also be combined, as SPA, PHA, ConA etc. with other biomacromolecules many.According to some physical behaviors of collaurum, as high electron density, grain size, shape and color reaction, add immunity and the biological characteristics of bond, thus make collaurum be widely used in the fields such as immunology, histology, pathology and cell biology.
The colored latex microsphere of surface band reactive group also can as the tracer agent of immunochromatography, the same with colloidal gold technique, colored latex mark immunity-chromatography technology also have easy and simple to handle, stable reagent, fast go out result, can the advantage such as room temperature preservation.Colored latex mark is by colored for different-diameter scope 0.1um-1um latex microsphere and containing ester class or other macromolecular substances covalent bond such as carboxyl, amino, hydroxyls, make color on these macromolecular marker, when enrichment forms macroscopic color stripes after stopping on detection line or nature controlling line.
Compare with chemoluminescence method with prior art ELISA, the advantage of immunochromatographyassay assay mainly comprises: (1) is fast easy to use, and be convenient to basic unit and use and onsite application, institute responds and can complete in 20 minutes; (2) cost is low, does not need special instrument and equipment; (3) applied range, can adapt to multiple testing conditions; (4) can carry out multinomial detection, if the more difficult acquisition of positive sample, multinomial detection can save sample, reduces costs; (5) label is stablized, and mark sample stores more than 2 year year at 4 DEG C, no signal relaxation phenomenon; (6) collaurum is originally as redness, does not need to add chromogenic agents, eliminates the step of enzyme target carcinogenicity substrate and stop buffer, to human non-toxic's evil.
In autoimmune disease diagnosis, there is more immune chromatography test paper, but at home and abroad still do not come out in market based on the immune chromatography test paper of anti-ASCA antibody test.
Summary of the invention
Technical matters to be solved by this invention is to overcome now methodical deficiency, immunochromatographic method is applied in the detection of anti-ASCA antibody, by antigen coated for ASCA in the detection zone of pad or analyzing film, realize special to the height of ASCA antibody anti-in sample, high sensitivity, high accuracy detection, rapid screening anti-ASCA antibody positive sample, for the autoimmune diseases such as clinical UC provide auxiliary diagnosis fast.
An object of the present invention is the immunochromatographydetecting detecting test strip and the preparation method that provide a kind of anti-ASCA antibody fast and accurately, and two of object is to provide a kind of anti-ASCA antibody detection method based on immunochromatography technique.
As the immunochromatographydetecting detecting test strip of a kind of anti-ASCA antibody of the present invention first aspect, comprise sample pad (1), pad (2), analyzing film (3), adsorptive pads (6) and base plate (7), analyzing film (3) is arranged detection zone (4) and quality control band (5), the top of described base plate (7) is fitted with analyzing film (3), the two ends on analyzing film (3) top are fitted with pad (2) and adsorptive pads (6) respectively, and the one end on pad (2) top is fitted with sample pad (1).
Described pad is 1 layer (Fig. 1) or 2 layers (Fig. 2), wherein 2 layers time stragglyly to overlap with analyzing film.
The preparation method of the immunochromatographydetecting detecting test strip of described anti-ASCA antibody, comprises the following steps:
The preparation of step 1.ASCA antigen
Prepared by step 2. pad (2)
(1) preparation of nano gold mark thing: with the nano-Au solution of 30 ~ 60nm particle diameter mark ASCA antigen, anti-human IgG antibodies, anti-human IgA antibody, staphylococcal protein A (SPA), streptococcal protein G (Protein G), and other and quality control band can form the albumen of immune complex.
(2) preparation of colored latex label: with the colored latex mark ASCA antigen of band active amino or carboxylic group, anti-human IgG antibodies, anti-human IgA antibody, staphylococcal protein A (SPA), streptococcal protein G (Protein G), and other and quality control band can form the albumen of immune complex.
(3) pad (2) preparation: glass fibre membrane or polymer PET are as pad, first use containing BSA and sugared damping fluid pre-service and dry, the nano gold mark thing that step (1) is prepared or latex label, be sprayed on pretreated glass fibre membrane or polymer PET with spraying instrument, drying for standby.
Prepared by step 3. analyzing film (3)
(1) detection zone (4) preparation: according to pad labelled protein type selecting detection zone coating protein, if the associated proteins on pad is containing ASCA, the coating protein of detection zone is anti-human igg and IgA.If containing anti-human igg and IgA on pad, detection zone coating protein is ASCA.
(2) quality control band (5) preparation: according to the coating protein of the labelled protein type selecting quality control band of pad, if pad labelled protein is single ASCA, the coating protein of quality control band is the antibody of anti-ASCA; If pad labelled protein is single anti-human igg and IgA antibody, the labelled protein of quality control band is the corresponding antibody of anti-human IgG antibodies or the antibody of anti-human IgA antibody; Or other pad labelled proteins form the albumen of immune complex.
Prepared by step 4. sample pad
Glass fibre membrane or polyester film are flooded dry for standby through damping fluid, or directly uses.
Step 5. test strips is assembled
The material completed made by step 1 ~ 4, by Fig. 1 or Fig. 2 overlap joint, cut into certain length and width according to the specification of base plate, in being arranged on base plate and getting stuck.Preferably, test strips length is 6.5cm, and width is 3mm or 4mm.
Described ASCA antigen obtains from brewing yeast cell wall extraction purification.
Described anti-human igg and IgA antibody are one or more monoclonal antibodies in mouse source, rabbit source, Yang Yuan, Ma Yuan, camel source or cavy source or polyclonal antibody.
The antibody of described anti-ASCA take ASCA as immunogenic, one or more monoclonal antibodies in mouse source, rabbit source, Yang Yuan, Ma Yuan, camel source or cavy source or polyclonal antibody.
Described anti-human igg and the antibody of IgA antibody refer to and can form the antibody of immune complex with this antibody, and such as this anti-human IgG antibodies is mouse-anti human IgG, and its antibody is the antibody of sheep anti-mouse igg or the mouse IgG antibody in other non-mouse sources.
In another aspect of this invention, provide a kind of anti-ASCA antibody detection method, by the anti-ASCA antibody immune chromatography test strips prepared by first aspect present invention method and step, measuring samples detected, concrete steps:
(1) sample process: get serum, blood plasma or whole blood sample, with sample loading buffer dilution 0 ~ 100 times;
(2) sample drop of above-mentioned process is added in the sample pad of test strips, leaves standstill 5 ~ 20 minutes, observe T line and C line;
(3) result interpretation: T line and C line all manifest, result is positive; T line does not manifest, and C line manifests, and result is negative; T line and C line all do not manifest, and prompting test paper lost efficacy.
Cleaning Principle of the present invention:
Select gold mark/latex etc. to mark ASCA antigen or other can object is combined in measuring samples albumen, be sprayed on pad, make pad, can be there is immunoreactive albumen with labelled protein-object albumen composition in bag in detection zone, when after in sample application to be checked to sample pad, ASCA antibody in sample and the labelled protein on pad form immune complex, due to capillary effect, this compound is to the swimming of adsorptive pads direction, this compound and the antigen generation specific immunity association reaction be coated in detection zone, form gold mark/latex protein-anti-ASCA antibody-ASCA antigen triplet compound and be trapped within detection line, enrichment forms darker aubergine band or latex colors gradually, because capillary effect continues swimming forward, special immune response is there is and is trapped in gold mark/latex rabbit igg with the goat anti-rabbit igg be coated on nature controlling line, be enriched in gradually on nature controlling line and form darker aubergine band or latex colors, unnecessary unconjugated material continues chromatography on adsorptive pads, and what therefore all occur band at detection line and nature controlling line is judged to positive findings, if not containing anti-ASCA antibody in blood serum sample, when labelled protein arrives detection line, not with the corresponding protein generation immune response be coated on detection line, therefore not there is developed band at detection line place, and there is special immune response to the corresponding coating protein being coated in nature controlling line place forward and be trapped in gold mark/latex rabbit igg continuation swimming, be enriched in gradually on nature controlling line and form aubergine band or latex colors, in Quality Control, therefore only occur that band is judged to negative findings.
Immunochromatography technique is applied to anti-ASCA antibody test by the present invention first, achieves high specific, highly sensitive detection perform.Compare with chemical luminescence reagent kit with the ELISA of existing bibliographical information, advantage of the present invention mainly comprises: detection time short (5 ~ 20min); Without any need for specific apparatus, can realize bedside detect and outpatient service immediately detect; Easy and simple to handle, only need single step reaction, operating personnel are without the need to training, and testing cost is low; To temperature without particular/special requirement, without the need to freezing, store convenient transportation, room temperature can preserve 24 months.
Accompanying drawing explanation
Side structure schematic diagram 1 when Fig. 1 pad of the present invention and detection zone are respectively 1.
Side structure schematic diagram 2 when Fig. 2 pad of the present invention is 2 layers.
Side structure schematic diagram 3 during Fig. 3 detection zone of the present invention 2.
Positive and negative findings schematic diagram 4 when Fig. 4 detection zone of the present invention is 1.Wherein 4a is band schematic diagram; 4b is positive findings; 4c is negative findings; 4d and 4e represents that test strips lost efficacy.
Positive and negative findings schematic diagram 5 when Fig. 5 detection zone of the present invention is 2.Wherein 5a is band schematic diagram; 5b is that IgG and IgA is all positive; 5c is that IgG is positive, and IgA is negative; 5d is that IgA is positive, and IgG is negative; 5e is negative findings; 5f and 5g represents that test paper lost efficacy.
Embodiment
ASCA antibody test immune chromatography test paper of the present invention, as shown in Figure 1, this test paper mutually pastes analyzing film (3), pad (2), sample pad (1), adsorptive pads (6) by side in turn with overlapping to opposite side on base plate (7).
Pad (2) is coated with gold mark/latex labelled protein, analyzing film (3) is arranged detection zone (4) and quality control band (5), according to the difference of labelled protein on pad, select corresponding detection zone coating protein and quality control band coating protein.Preferably, the labelled protein that pad sprays is ASCA antigen and mouse IgG, then the coating protein in detection zone is anti-human igg and IgA antibody, and the coating protein on quality control band is against murine IgG.Another is preferred, and the labelled protein that pad sprays is anti-human igg and IgA antibody, then the coating protein in detection zone is ASCA antigen.
Below in conjunction with specific embodiments and the drawings, set forth the present invention further.
Prepared by embodiment 1.ASCA antigen
Reference literature (Liu Hongzhi etc., Food Science, 2008, Vol.29, No.05 465), select alkaline process lixiviate, by centrifugal after 80 DEG C of process 90min for the brewing yeast cell 6%KOH cleaned, in supernatant, add Fehling's reagent, 0 DEG C of reaction 15min, precipitation 0.5N NaCI is dissolved in the HCl of 4N after cleaning, by 2 times of volume ethanol precipitations, pass through glass fiber filter, cleaning is dry afterwards obtains mannan, this glycan contains 20% albumen, can be marked liquid and latex solution marks by gold, also can be combined on cellulose membrane.
Prepared by embodiment 2 antibody
Pad and detection zone coated antibody anti-human igg monoclonal antibody and polyclonal antibody, and for the monoclonal antibody of quality control band and other animal origins of pad and polyclonal antibody, obtain by immune animal.
1, the concrete operation method of monoclonal antibody preparation is:
By 0.05mg ~ 5mg immune formulation (respectively for goat, mouse, rabbit, horse and cavy) and the Freund's complete adjuvant of 1 times of volume are mixed to get injection solution, by the multiple location injection in Animal Skin of this injection solution;
After one month by Freund's complete adjuvant mixed liquor through multiple location Animal Skin hemostasis booster immunization.By animal bloodletting after 7 ~ 14 days, measure antiserum titre.
To animal booster immunization until titre reaches plateau.By merging from by the animal of immunity recovery splenocyte and murine myeloma cell SP2/0, the hybridoma of energy stably express object antibody after screening, can be obtained.
The hybridoma of in vitro culture, Mice Inoculated or rat abdominal cavity, get ascites purifying and obtain monoclonal antibody; Or purifying obtains monoclonal antibody from culture supernatant.
2, polyclonal antibody preparation:
With monoclonal antibody step 1) and 2), after acquisition antiserum, purifying antiserum obtains polyclonal antibody.
3, staphylococcal protein A and streptococcal protein G preparation
According to the gene order of staphylococcal protein A and streptococcal protein G, prepare by escherichia coli prokaryotic expression cloned gene, concrete operation method can see (Molecular Cloning: A Laboratory guide), or the step of embodiment 1ASCA.
The each component preparation of embodiment 3 gold test strip
1, collaurum liquid preparation
The HAuCl4 solution of 0.01% (w/v) is heated to boiling, adds rapidly every 100mL HAuCl
4solution adds appropriate reductant solution, and color is from blueness, then light blue, blue, then heating occurs red, boils 7 ~ 10min and occurs transparent orange red.Filter with ultrafiltration or miillpore filter (0.45 μM) again, to remove polymkeric substance wherein and other impurity that may be mixed into.The collaurum outward appearance prepared should pure, bright, without precipitation and floating thing, abandon when grease and a large amount of black particle shape sediment impurity appear in liquid level.
Wherein used reductive agent can be trisodium citrate, tannic acid-trisodium citrate, white phosphorus, preferably uses trisodium citrate, more preferably uses 1% (w/v) trisodium citrate.
Wherein absolute cleanliness answered by glass container used, with before need through pickling.Its water should be deionization ultrapure water, and resistivity reaches 18.2M Ω.
In colloidal gold solution preparation process, the compound method of each solution is as follows: HAuCl
4preparation: with ultrapure water dissolved chlorine auric acid, be made into 1% solution, put 4 DEG C for subsequent use, the term of validity three months; 1000mL1%HAuCl
4solution formula: 10g HAuCl
4, ultrapure water is settled to 1000mL; The preparation of 1% trisodium citrate (Sodium Citrate): dissolve Sodium Citrate with ultrapure water, be made into 1% solution, 0.22 μM of membrane filtration mistake, now with the current.
2, gold mark albumen preparation
The present invention's gold to be marked mark albumen includes but not limited to many anti-, the ASCA antigen of many anti-, the goat-anti people IgA of mouse-anti people IgA monoclonal antibody, horse IgM, mouse IgG, Protein G, sheep IgA, sheep IgG, guinea pig anti-human IgG, mouse IgG, SPA, rabbit anti-human igg's monoclonal antibody, the anti-human IgA of horse many anti-, rabbit IgM, mouse IgA, cavy IgE.
Collaurum pH6.8 ~ 8.5 are regulated with 0.1M sodium carbonate, 5 ~ 25 μ G albumen to be marked is slowly added by every milliliter of colloidal gold solution, mixing, leave standstill 10 ~ 30min, then add BSA to final concentration 0.5 ~ 1%, mixing, leave standstill 5 ~ 10min, the centrifugal 5min of 3000rpm, go precipitation, upper solution is gone to new pipe, the centrifugal 30min of 9000rpm, remove supernatant, add re-suspension liquid to commercial weight, solution is moved to new pipe, 9000rpm is centrifugal 30min again, add and will precipitate resuspended with the conserving liquid of 1/10th initial volumes, put 4 DEG C for subsequent use.
3, analyzing film preparation
Analyzing film is selected: the optional nitrocellulose filter of material (NC) of analyzing film or cellulose acetate membrane, commercial nitrocellulose filter comprises S & SAE99, whatman8 μm, millipore M135, sartorius CN140 etc.The concrete NC film or the cellulose acetate membrane that use which kind of specification are not keys of the present invention, but in each mensuration, above-mentioned several NC film can as preferably.The film of the different damping fluid process containing different surfaces activating agent that different manufacturers uses, gap is in various degree had with detection line antibody-solutions affinity used, also can largely cause lines uneven, traction or the phenomenon of disperse, therefore use assembling test paper to select preferred NC film or cellulose acetate membrane.
Prepared by analyzing film: be buffered liquid dilution detection zone coating protein to 0.5 ~ 4.0mG/mL concentration with bag, with drawing film gold spraying instrument HM3035, distance pad 1cm place, be sprayed on film with 0.5 ~ 2.0 μ L/cm, form detection zone (4), distance detection zone is about 5mm place, is sprayed on same film with 0.5 ~ 2.0 μ L/cm with drawing film gold spraying instrument instrument, form quality control band (5), quality control band simultaneously distance adsorptive pads is about 1cm.Analyzing film 37 DEG C oven dry, encapsulates for subsequent use.
It can be borate, carbonate, phosphate, Tris-HCl or Tris-phosphate etc. that the bag used is buffered liquid, the effect of damping fluid is to provide certain pH and ionic strength makes albumen firmly be coated in NC film, pH of cushioning fluid is generally about in 6 ~ 9.5 scopes, be preferably within the scope of the neutral buffered of 6.5 ~ 7.5, and most preferably the pH value of damping fluid is in 7.0 ~ 7.4 scopes.
A. analyzing film 1
Detection zone 1: by goat anti-human igg and pH be 7.1 10mM PB buffer solution mixed preparing become the solution that concentration is 0.3mG/mL, be sprayed on nitrocellulose membrane, coating weight is 1 μ L/cm.
Detection zone 2: by mouse-anti people IgA and pH be 7.2 10mM PB buffer solution mixed preparing become the solution that concentration is 0.2mG/mL, be sprayed on nitrocellulose membrane, coating weight is 1 μ L/cm.
Quality control band: by mouse-anti horse IgG and pH be 7.3 10mM PB buffer solution mixed preparing to become concentration be 0.5mG/mL mixed solution, be sprayed on nitrocellulose membrane, coating weight is 1 μ L/cm.
B. analyzing film 2
Detection zone 1: it is 0.4mG/m that the 10mM carbonate buffer solution being 7.2 by mouse-anti human IgG and pH is mixed with concentration respectively, is sprayed on cellulose acetate film, coating weight is 1 μ L/cm.
Detection zone 2: anti-human IgA and the pH of horse be 7.2 10mM carbonate buffer solution to be mixed with concentration be respectively 0.3mG/m, be sprayed on cellulose acetate film, coating weight is 1 μ L/cm.
Quality control band: be the 10mM carbonate buffer solution preparation sheep anti-mouse igg of 7.5 with pH, concentration is 0.2mG/mL, is sprayed on cellulose acetate film, and coating weight is 1 μ L/cm.
C. analyzing film 3
Detection zone: be the 10mM PB buffer preparation ASCA antigen of 7.5 with pH, concentration is 3mg/mL, is sprayed on nitrocellulose membrane, and coating weight is 1.2 μ L/cm.
Quality control band: be the 10mM PB buffer preparation mouse-anti sheep IgA monoclonal antibody of 7.1 with pH, concentration 0.2mG/mL, is sprayed on nitrocellulose membrane, and coating weight is 1 μ L/cm.
D. analyzing film 4
Detection zone: be the 10mM PB buffer preparation ASCA antigen of 7.3 with pH, concentration is 2mg/mL, is sprayed on cellulose acetate film, and coating weight is 1 μ L/cm.
Quality control band: be the anti-sheep IgA of 10mM PB buffer preparation rabbit of 7.0 with pH, concentration is 0.2mG/mL, is sprayed on cellulose acetate film, and coating weight is 1.0 μ L/cm.
4, the preparation of pad
The process of pad: pad material is all-glass paper or polyester film, pad is soaked with the pad treating fluid prepared, after at 37 DEG C, 1h is dried, antibody or albumen are sprayed on pretreated polymer PET with the consumption of 4uL/cm, obtain pad after 37 DEG C of dry 1h, pad is for subsequent use under being placed in the environment of 2 ~ 8 DEG C; Consisting of of pad treating fluid: pH is the 10mM PB buffer solution of 7.0 ~ 9.0, containing 1%BSA, and 10 ~ 20% sucrose, 0.1%Tween-20.Pad also can not do pre-service, directly uses.
A. pad 1 glass fibre membrane, double-deck, 2a layer is ASCA antigen, and 2b layer is horse IgM.
B. pad 2 polyester film, individual layer, ASCA antigen and mouse IgG.
C. pad 3 polyester film, double-deck, Protein G and sheep IgA.
D. pad 4 glass fibre membrane, individual layer, goat-anti people IgA and guinea pig anti-human IgG
5, the preparation of sample pad
Sample pad material is all-glass paper or polyester film, soaks sample pad with the sample pad treating fluid prepared, and at 37 DEG C, 1h is dried, consisting of of sample pad damping fluid: pH is the 10Mm PB buffer solution of 7.0 ~ 9.0, containing 1%BSA, 10% sucrose, 0.1%Tween-20.Sample pad also can not be done pre-service and directly use.
Prepared by embodiment 4 colloid gold label anti-ASCA antibody test test paper 1 ~ 5
The wide fillet of 1.7cm, 0.8cm, 2.5cm and 1.5cm sheared respectively by the sample pad of also drying embodiment 3 prepared with guillotine, pad, analyzing film, thieving paper, large plate is overlapped to form by Fig. 1 or Fig. 2 mode, with cutting cutter, large plate is cut into single part, the difference that every person-portion width gets stuck according to base plate and different, preferred 3mm and the 4mm width of the present invention.Be assembled in the test card got ready by the test paper that single part has cut, make the sample pad of the corresponding test paper of application of sample window, the corresponding detection zone of result display window and quality control region, during assembling, temperature controls at 25 ~ 37 DEG C, humidity 20 ~ 30%.
Each component of gold label test strip 1 ~ 5 is as following table:
The colored latex labelled protein preparation of embodiment 5.
1, the preparation of colored latex marking fluid
Latex covalent activated: ultrasound wave process latex microsphere body 30 seconds, regulates latex microsphere bulk concentration to be 1.0 × 10
12centrifugal 10 minutes of/mL, 15000rpm, collected after centrifugation sediment distilled water dissolves, and disperses 30 seconds with 200W ultrasound wave; First add the 50mg/mL EDC of 50 μ L, vibration mixing, then add the 50mg/mL N-hydroxy thiosuccinimide of 50 μ L, vibration mixing, equilibrate at room temperature after 30 minutes at 15000rpm centrifugal 10 minutes, precipitation 50mM citrate buffer solution dissolves, and is statically placed in 4 DEG C of refrigerators.
2, the preparation of colored latex labelled protein
The present invention's albumen to be marked includes but not limited to: horse anti-human igg, mouse-anti people IgA, SPA, rabbit IgM, ASCA antigen, sheep IgG, cavy IgE.
By the latex after activation in 200W ultrasound wave process 30 seconds, antibody to be marked or albumen is added according to the ratio of the colored latex of 100 ~ 300 μ G-protein/100 μ L, mixing stirring at room temperature reaction 1 ~ 2 hour, centrifuge washing, under each 15000rpm centrifugal 10 minutes, wash 3 times altogether, precipitate and to dissolve with PBS-TBN and 100W ultrasound wave process 30 seconds, then be diluted to centrifugal front volume with PBS-TBN, 4 DEG C save backup.
3, analyzing film preparation
Analyzing film material, bag are buffered formula of liquid and method for coating with embodiment 3, and the present embodiment is following 4 kinds of analyzing films preferably:
A. analyzing film 1 cellulose acetate film
T line: rabbit anti-human igg, it is pH7.2 10mM PB, protein concentration 0.3mG/ μ L, coating weight 1 μ L/cm that bag is buffered liquid.
C line: with the 10mM PB of pH value 7.2, dilution mouse-anti OmpC monoclonal antibody, concentration is respectively 0.3mG/ μ L, and coating weight is 1 μ L/cm.
B. analyzing film 2 nitrocellulose membrane
T line: goat anti-human igg and the anti-human IgA of rabbit, it is pH7.3 10mM PB that bag is buffered liquid, prepares protein concentration 0.5mG/ μ L and 0.6mG/ μ L respectively, 1: 1 mixing, coating weight 1 μ L/cm.
C line: with the 10mM PB of pH value 7.2, dilution goat-anti rabbit IgM, concentration 0.2mG/ μ L, coating weight is 1 μ L/cm.
C. analyzing film 3 nitrocellulose membrane
T line: it is that the 10mM PB of pH6.7 prepares that ASCA antigen bag is buffered liquid, and concentration is respectively 2.5mG/ μ L, coating weight 1 μ L/cm.
C line: with the 10mM PB of pH value 7.3, dilution cavy anti-sheep IgG, concentration 0.3mG/ μ L, coating weight is 1 μ L/cm.
D. analyzing film 4 cellulose acetate film
T line: it is that the 10mM PB of pH6.5 prepares that camel anti-human igg bag is buffered liquid, and concentration is respectively 0.2mG/ μ L, coating weight 1 μ L/cm.
C line: with the 10mM PB of pH value 6.8, dilution goat-anti cavy IgE, concentration 0.3mG/ μ L, coating weight is 1 μ L/cm.
4, pad preparation
Pad pre-service: polymer PET or glass fibre membrane are soaked 30 minutes with pad damping fluid, 37 DEG C of oven dry, the albumen stroke film gold spraying instrument that colored latex marks, are sprayed on pretreated film with the consumption of 2 ~ 6 μ L/cm, 37 DEG C of dryings, put 2 ~ 8 DEG C for subsequent use.Pad buffer formulation is with embodiment 3, and the present embodiment is following 4 kinds of pads preferably:
A. pad 1: polyester film, 2 layers, 2a is horse anti-human igg and the mouse-anti people IgA of red latex mark, and 5 μ L/cm spray, and 2b layer is the OmpC albumen of purple latex mark, and 4 μ L/cm spray.
B. pad 2: polyester film, 2 layers, 2a layer is the ASCA of red latex mark, and 2b layer is the rabbit IgM of blue latex mark, and 3 μ L/cm and 4 μ L/cm spray respectively.
C. pad 3: glass fibre membrane, 2 layers, 2a is the anti-human IgA of purple latex mark horse, and 4 μ L/cm spray, and 2b is the foster IgG of red latex mark, and 4 μ L/cm spray.
D. pad 4: glass fibre membrane, 2 layers, 2a is the ASCA of purple latex mark, and 5 μ L/cm spray, and 2b is the cavy IgE of blue latex mark, and 3 μ L/cm spray.
5, the preparation of sample pad
Sample pad material is all-glass paper or polyester film, soaks sample pad with the sample pad treating fluid prepared, and at 37 DEG C, 1h is dried, consisting of of sample pad damping fluid: pH is the 10Mm PB buffer solution of 7.0 ~ 9.0, containing 1%BSA, 10 ~ 20% sucrose, 0.1%Tween-20.Sample pad also can not be done pre-service and directly use.
The colored latex of embodiment 6 anti-ASCA antibody test test paper 1 ~ 3 is assembled
The wide fillet of 1.7cm, 0.8cm, 2.5cm and 1.5cm sheared respectively by the sample pad of also drying embodiment 3 prepared with guillotine, pad, analyzing film, thieving paper, large plate is overlapped to form by Fig. 1 or Fig. 2 mode, with cutting cutter, large plate is cut into single part, the difference that every person-portion width gets stuck according to base plate and different, preferred 3mm and the 4mm width of the present embodiment.Be assembled in the test card got ready by the test paper that single part has cut, make the sample pad of the corresponding test paper of application of sample window, the corresponding detection zone of result display window and quality control region, during assembling, temperature controls at 25 ~ 37 DEG C, humidity 20 ~ 30%.
Each component of colored latex test strips 1 ~ 4 is as following table:
Embodiment 7 sample process
Serum sample: get whole blood 1 ~ 5mL in serum collection pipe, leaves standstill the centrifugal 5 ~ 10min of 30min ~ 2h, 3000 ~ 5000g, gets supernatant and get final product.According to the accuracy of detection of test strips, sample sample loading buffer dilution 0-100 times, get 50-100 μ L and be added drop-wise in the well of test strips, leave standstill observations after 5 ~ 20 minutes.
Plasma sample: get whole blood 1 ~ 5mL and mix in sodium citrate or liquaemin anticoagulant tube, the centrifugal 5 ~ 10min of 1000 ~ 3000g, gets supernatant and namely obtain plasma sample.According to the accuracy of detection of test strips, sample sample loading buffer dilution 0-100 times, get 50-100 μ L and be added drop-wise in the well of test strips, leave standstill observations after 5 ~ 20 minutes.
Whole blood sample: fetching point or ear-lobe fresh blood about 50 μ L, be added drop-wise in well, is added drop-wise in well with 50 μ L sample loading buffers at once and dilutes, leave standstill observations after 5 ~ 20 minutes.
Embodiment 8 test strips Performance Evaluation
The performance of reagent strip of the present invention comprise stability, batch in inaccuracy and batch between inaccuracy assessment.
1,37 DEG C of accelerated aging tests
Test strips is placed 37 DEG C, the withinrun precision of the yin and yang attribute coincidence rate of each 10 parts of taking-up every day quality-control product harmonizing yinyang reference material judges the stability of test paper.After 4 months, the yin and yang attribute coincidence rate of quality-control product and each yin and yang attribute reference material is 100%.Infer that the shelf-life of test strips is more than 18 months.
2, interior inaccuracy is criticized
Get gold label test strip and the latex test strips of each one batch, respectively with high, medium and low three kinds of positive serums and each portion of negative serum, every part of serum uses gold label test strip and latex test strips duplicate detection 10 times respectively, the testing result of all positive serums is the positive, the testing result of all negative serums is feminine gender, points out colloidal gold strip of the present invention and latex test strips to criticize interior inaccuracy and meets standard.Table specific as follows:
3, criticize between inaccuracy
Test strips 1 and each three batches of test strips 7, detect with high, medium and low three kinds of positive serums and negative serum, every part of Virus monitory 10, observations after 10 minutes also inserts following table, result shows, test strips 1 is consistent with the testing result of each three different batches of test strips 8, illustrates that between criticizing, inaccuracy meets sample.
Embodiment 9 ELISA test strip and clinical performance assessment
The gold label test strip prepared by embodiment 4 and embodiment 6 prepare the CD patients serum or each 100 examples of blood plasma that latex ELISA test strip makes a definite diagnosis, parallel control is made with the ELISA of American I NOVA kit IgG-ASCA and IgA-ASCA, IgG and the arbitrary positive of IgA antibody are the positive, calculate positive coincidence rate and negative match-rate, and total coincidence rate.Testing result following table:
Positive coincidence rate=the 116/122=95.08% of gold label test strip 1, negative match-rate=73/78=93.59%, total coincidence rate=(116+73)/200=94.5%.
Positive coincidence rate=the 112/119=94.12% of colored latex test strips 3, negative match-rate=76/81=93.83%, total coincidence rate=(112+76)/200=94.0%.
According to above result, the clinical performance of gold-labeled strip and colored latex reagent strip meets expection, suitable with the detection perform of existing product.Above embodiment is the description of this invention and non-limiting.
Claims (9)
1. an anti-ASCA antibody immune chromatography test strips, comprise sample pad (1), pad (2), analyzing film (3), adsorptive pads (6), base plate (7), detection zone (4) and quality control band (5), the top of described base plate (7) is fitted with analyzing film (3), the two ends on described analyzing film (3) top are fitted with pad (2) and adsorptive pads (6) respectively, the one end on described pad (2) top is fitted with sample pad (1), described detection zone (4) and quality control band (5) are arranged on analyzing film (3), it is characterized in that, ASCA antigen is combined on pad (2) or is coated in detection zone (4).
2. ASCA antibody test test strips according to claim 1, is characterized in that, described pad is 1 layer, overlaps as shown in Figure 1 with analyzing film.
3. ASCA antibody test test strips according to claim 1, is characterized in that, described pad divide (2a), under (2b) two-layer with analyzing film overlap joint straggly (Fig. 2).
4. a preparation method for anti-ASCA antibody immune chromatography test strips, comprises the steps:
The preparation of step 1.ASCA antigen
Prepared by step 2. pad (2)
(1) preparation of nano gold mark thing: with nano-Au solution mark ASCA antigen, anti-human IgG antibodies, anti-human IgA antibody, staphylococcal protein A (SPA), streptococcal protein G (Protein G), and other and quality control band can form the albumen of immune complex.
(2) preparation of latex label: with the latex mark ASCA antigen of band reactive group, anti-human IgG antibodies, anti-human IgA antibody, staphylococcal protein A (SPA), streptococcal protein G (Protein G), and other and quality control band can form the albumen of immune complex.
(3) pad (2) preparation: glass fibre membrane or polymer PET are as pad, and the nano gold mark thing prepare step (1) or latex label, be sprayed on glass fibre membrane or polymer PET, drying for standby.
Prepared by step 3. analyzing film (3)
A. detection zone (4) preparation: according to pad labelled protein type selecting detection zone coating protein, if the associated proteins on pad is containing ASCA, the coating protein of detection zone is that anti-human igg is or/and IgA.If pad contains anti-human igg or/and IgA, detection zone coating protein is ASCA.
B. quality control band (5) preparation: according to the coating protein of the labelled protein type selecting quality control band of pad, if pad labelled protein is single ASCA, the coating protein of quality control band is the antibody of anti-ASCA; If pad labelled protein be single anti-human igg or/and IgA antibody, the labelled protein of quality control band is corresponding anti-human igg or the antibody of IgA antibody; When pad labelled protein has 2 layers, the coating protein of quality control band can form the albumen of immune complex with pad respective layer associated proteins.
Prepared by step 4. sample pad
Glass fibre membrane or polyester film are flooded dry for standby through damping fluid, or directly uses.
Step 5. test strips is assembled
The material completed made by step 1 ~ 4, by Fig. 1 or Fig. 2 overlap joint, cut into certain length and width according to the specification of base plate, in being arranged on base plate and getting stuck.
5. immuno-chromatographic test paper strip according to claim 4, is characterized in that: described ASCA antigen obtains from brewing yeast cell wall extraction purification.
6. immuno-chromatographic test paper strip according to claim 4, is characterized in that, described anti-human igg and IgA antibody are one or more antibody in mouse source, rabbit source, Yang Yuan, Ma Yuan, camel source or cavy source.
7. immuno-chromatographic test paper strip according to claim 4, is characterized in that, the antibody of described anti-ASCA take ASCA as immunogenic, one or more monoclonal antibodies in mouse source, rabbit source, Yang Yuan, Ma Yuan, camel source or cavy source or polyclonal antibody.
8. immuno-chromatographic test paper strip according to claim 4, is characterized in that, described anti-human igg and the antibody of IgA antibody refer to and can form the antibody of immune complex with this antibody.
9. an anti-ASCA antibody detection method, is characterized in that, with the immuno-chromatographic test paper strip described in claim 1-8, detect measuring samples, concrete steps comprise:
(1) sample process: get serum, blood plasma or whole blood sample;
(2) sample drop is added in the sample pad of test strips, leaves standstill 5 ~ 30 minutes, observe T line and C line;
(3) result interpretation: T line and C line all manifest, result is positive; T line does not manifest, and C line manifests, and result is negative; Other situations prompting test paper lost efficacy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410412017.8A CN104991067A (en) | 2014-08-20 | 2014-08-20 | Preparation method and applications of anti-ASCA antibody test paper |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410412017.8A CN104991067A (en) | 2014-08-20 | 2014-08-20 | Preparation method and applications of anti-ASCA antibody test paper |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104991067A true CN104991067A (en) | 2015-10-21 |
Family
ID=54302906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410412017.8A Pending CN104991067A (en) | 2014-08-20 | 2014-08-20 | Preparation method and applications of anti-ASCA antibody test paper |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104991067A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110824177A (en) * | 2019-09-11 | 2020-02-21 | 润和生物医药科技(汕头)有限公司 | Rapid detection test paper and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040137536A1 (en) * | 2002-10-25 | 2004-07-15 | Boone James Hunter | Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel |
| CN102062777A (en) * | 2009-11-12 | 2011-05-18 | 上海科新生物技术股份有限公司 | Hepatopathy detecting test paper by colloidal gold chromatography and preparation method thereof |
| CN103175971A (en) * | 2013-02-28 | 2013-06-26 | 苏州和锐医药科技有限公司 | IgA antibody detection kit |
| CN204666639U (en) * | 2014-08-20 | 2015-09-23 | 苏州和锐医药科技有限公司 | A kind of anti-ASCA antibody immune chromatography test strips |
-
2014
- 2014-08-20 CN CN201410412017.8A patent/CN104991067A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040137536A1 (en) * | 2002-10-25 | 2004-07-15 | Boone James Hunter | Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel |
| CN102062777A (en) * | 2009-11-12 | 2011-05-18 | 上海科新生物技术股份有限公司 | Hepatopathy detecting test paper by colloidal gold chromatography and preparation method thereof |
| CN103175971A (en) * | 2013-02-28 | 2013-06-26 | 苏州和锐医药科技有限公司 | IgA antibody detection kit |
| CN204666639U (en) * | 2014-08-20 | 2015-09-23 | 苏州和锐医药科技有限公司 | A kind of anti-ASCA antibody immune chromatography test strips |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110824177A (en) * | 2019-09-11 | 2020-02-21 | 润和生物医药科技(汕头)有限公司 | Rapid detection test paper and preparation method and application thereof |
| CN110824177B (en) * | 2019-09-11 | 2021-06-11 | 润和生物医药科技(汕头)有限公司 | Rapid detection test paper and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102062777B (en) | Hepatopathy detecting test paper by colloidal gold chromatography and preparation method thereof | |
| AU757405B2 (en) | Integrated assay device and methods of production and use | |
| JPH03176659A (en) | Chromatography-strip coupled assay apparatus | |
| CN104502586A (en) | Immunochromatography detection method and test paper | |
| CN104297465A (en) | Anti-OmpC antibody detection test paper preparation method and purpose thereof | |
| CN105628932A (en) | SAA (serum amyloid A) immunochromatographic test strip and preparation method and test method thereof | |
| CN102135535A (en) | Immune colloidal metal detection technology capable of directly performing semi-quantitative analysis, preparation method and application | |
| JP5010374B2 (en) | Use of bovine albumin p-aminophenyl N-acetyl β-D glucosaminide as a control system for immunoassay devices | |
| CN104090109A (en) | Colloidal gold immunochromatography test paper and colloidal gold immunochromatography test method for quickly detecting human blood procalcitonin | |
| JPH02504188A (en) | Capillary device for multiple analysis immunoassays | |
| US20170234896A1 (en) | Lateral flow immunoassays for the detection of antibodies against biological drugs | |
| CN206038696U (en) | Ration calprotectin detects immunochromatographic test strip | |
| CN104297488A (en) | Anti-CBir1 antibody detection test paper preparation method and purpose thereof | |
| CN104764881A (en) | Preparation method and application of anti-MPO-ANCA antibody immunity chromatography test paper | |
| CN206038688U (en) | Immunity chromatography detection test strip's fluorescent quantitation spectral detection system | |
| CN104198698A (en) | CUB and zona pellucida-like domains-containing protein 1 (CUZD1) antibody chromatography test strip and usage thereof | |
| CN102621315B (en) | Colloidal gold chromatography anti-Ro52 antibody detection test paper and preparation method thereof | |
| CN104297489A (en) | Anti-PR3-ANC antibody detection test paper preparation method and purpose thereof | |
| CN104764884A (en) | Preparation method and application of anti-alpha-enolase antibody chromatography test strip | |
| CN104991067A (en) | Preparation method and applications of anti-ASCA antibody test paper | |
| CN204666639U (en) | A kind of anti-ASCA antibody immune chromatography test strips | |
| CN104297466A (en) | Anti-I2 antibody chromatography test strip and purpose thereof | |
| RU169868U1 (en) | Test system for immunochromatographic determination of procalcitonin in samples of whole blood, serum or plasma for the rapid diagnosis of sepsis | |
| CN102621311B (en) | Colloidal gold chromatography anti-SSB antibody detection test paper and preparation method thereof | |
| CN102621312B (en) | Colloidal gold chromatography hepatopathy detection test paper and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 No. 218 building 313 room B2 Applicant after: Suzhou sharp Biotechnology Co., Ltd. Address before: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 No. 218 building 313 room B2 Applicant before: Suzhou Herui Medical Technology Co., Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151021 |
|
| RJ01 | Rejection of invention patent application after publication |